Re: 'Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis' by Tleyjeh et al

Affiliations

• ¹ Medical Sciences Division, University of Oxford, Oxfordshire, UK.
• ² Department of Respiratory Sciences, University of Leicester, Leicester, UK; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, UK.
• ³ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK. Electronic address: joseph.barker@nhs.net.